CDNA
CDNA
NASDAQ · Biotechnology

Caredx Inc

$18.30
+0.46 (+2.58%)
As of Mar 25, 2:10 PM ET ·
Financial Highlights (FY 2026)
Revenue
302.88M
Net Income
47.68M
Gross Margin
67.2%
Profit Margin
15.7%
Rev Growth
+4.0%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.2% 67.2% 39.5% 39.5%
Operating Margin 12.2% 11.0% -17.7% -19.5%
Profit Margin 15.7% 15.0% -18.5% -18.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 302.88M 291.12M 329.37M 271.09M
Gross Profit 203.41M 195.51M 130.20M 107.16M
Operating Income 36.98M 31.99M -58,208,720 -52,994,442
Net Income 47.68M 41.25M -60,795,749 -51,228,951
Gross Margin 67.2% 67.2% 39.5% 39.5%
Operating Margin 12.2% 11.0% -17.7% -19.5%
Profit Margin 15.7% 15.0% -18.5% -18.9%
Rev Growth +4.0% +4.0% -9.3% +22.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 344.44M 346.18M
Total Equity 455.35M 445.81M
D/E Ratio 0.76 0.78
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 39.58M 36.14M -79,903,104 -63,531,119
Free Cash Flow -60,969,564 -57,293,986